article

Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximab

Bertrand Coiffier, Weimin Li, Erin D Henitz, Jayaprakash D Karkera, Reyna Favis and 22 more (2013) CLINICAL CANCER RESEARCH

Reference details